Literature DB >> 8094005

Regulation of initial vinblastine influx by P-glycoprotein.

D R Shalinsky1, A P Jekunen, J E Alcaraz, R D Christen, S Kim, S Khatibi, S B Howell.   

Abstract

P-glycoprotein (PGP) is an energy-dependent efflux pump that serves to protect cells against the cytotoxicity of many natural product drugs including vinblastine (VBL). In this study we investigated the role of PGP in regulating initial VBL influx. The apparent influx of VBL, measured over the first 20 s, was 2-fold lower in KB-GRC1 cells expressing a transfected mdr1 gene at high level than in non-expressing parental KB-3-1 cells. Inhibition of PGP efflux function with dipyridamole increased the influx rate constant by 4.0-fold in the KB-GRC1 cells but only 2.1-fold in the KB-3-1 cells. Verapamil, another inhibitor of PGP-mediated efflux, increased the initial influx rate constant by 2.7-fold in the KB-GRC1 cells but only 1.4-fold in the KB-3-1 cells. Inhibition of PGP function by depletion of ATP increased influx by 6.8-fold and 2.2-fold in the two cell types, respectively. Mutation of PGP at both ATP binding sites abolished its ability to limit initial influx. Thus, VBL is serving as an efficient substrate for the efflux pump even within the first few seconds of drug exposure, consistent with the hypothesis that PGP may directly efflux drug from the cell membrane.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8094005      PMCID: PMC1968208          DOI: 10.1038/bjc.1993.6

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  36 in total

1.  Photoaffinity labeling of the multidrug-resistance-related P-glycoprotein with photoactive analogs of verapamil.

Authors:  A R Safa
Journal:  Proc Natl Acad Sci U S A       Date:  1988-10       Impact factor: 11.205

2.  Multidrug resistance: P-glycoprotein and its allies--the elusive foes.

Authors:  B A Chabner; A Fojo
Journal:  J Natl Cancer Inst       Date:  1989-06-21       Impact factor: 13.506

3.  Commercially available firefly luciferase reagents.

Authors:  F R Leach; J J Webster
Journal:  Methods Enzymol       Date:  1986       Impact factor: 1.600

Review 4.  The cell biology of multiple drug resistance.

Authors:  W T Beck
Journal:  Biochem Pharmacol       Date:  1987-09-15       Impact factor: 5.858

5.  Competitive inhibition by verapamil of ATP-dependent high affinity vincristine binding to the plasma membrane of multidrug-resistant K562 cells without calcium ion involvement.

Authors:  M Naito; T Tsuruo
Journal:  Cancer Res       Date:  1989-03-15       Impact factor: 12.701

6.  An altered pattern of cross-resistance in multidrug-resistant human cells results from spontaneous mutations in the mdr1 (P-glycoprotein) gene.

Authors:  K H Choi; C J Chen; M Kriegler; I B Roninson
Journal:  Cell       Date:  1988-05-20       Impact factor: 41.582

7.  Multifactorial resistance to adriamycin: relationship of DNA repair, glutathione transferase activity, drug efflux, and P-glycoprotein in cloned cell lines of adriamycin-sensitive and -resistant P388 leukemia.

Authors:  A M Deffie; T Alam; C Seneviratne; S W Beenken; J K Batra; T C Shea; W D Henner; G J Goldenberg
Journal:  Cancer Res       Date:  1988-07-01       Impact factor: 12.701

8.  Certain calcium channel blockers bind specifically to multidrug-resistant human KB carcinoma membrane vesicles and inhibit drug binding to P-glycoprotein.

Authors:  M M Cornwell; I Pastan; M M Gottesman
Journal:  J Biol Chem       Date:  1987-02-15       Impact factor: 5.157

9.  Effect of calcium antagonists on the chemosensitivity of two multidrug-resistant human tumour cell lines which do not overexpress P-glycoprotein.

Authors:  S P Cole; H F Downes; M L Slovak
Journal:  Br J Cancer       Date:  1989-01       Impact factor: 7.640

10.  Potentiation of some anticancer agents by dipyridamole against drug-sensitive and drug-resistant cancer cell lines.

Authors:  K Asoh; Y Saburi; S Sato; I Nogae; K Kohno; M Kuwano
Journal:  Jpn J Cancer Res       Date:  1989-05
View more
  9 in total

Review 1.  Overcoming transporter-mediated multidrug resistance in cancer: failures and achievements of the last decades.

Authors:  Miglė Paškevičiūtė; Vilma Petrikaitė
Journal:  Drug Deliv Transl Res       Date:  2019-02       Impact factor: 4.617

Review 2.  Cotransport of salt and water in membrane proteins: membrane proteins as osmotic engines.

Authors:  T Zeuthen; W D Stein
Journal:  J Membr Biol       Date:  1994-02       Impact factor: 1.843

3.  Unidirectional fluxes of rhodamine 123 in multidrug-resistant cells: evidence against direct drug extrusion from the plasma membrane.

Authors:  G A Altenberg; C G Vanoye; J K Horton; L Reuss
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-24       Impact factor: 11.205

4.  Effect of natural flavonoids to reverse P-glycoprotein-related multidrug resistance in breast cancer cell cultures.

Authors:  Miglė Paškevičiūtė; Vilma Petrikaitė
Journal:  Am J Cancer Res       Date:  2022-06-15       Impact factor: 5.942

Review 5.  P-glycoprotein-mediated multidrug resistance in normal and neoplastic hematopoietic cells.

Authors:  T Licht; I Pastan; M Gottesman; F Herrmann
Journal:  Ann Hematol       Date:  1994-10       Impact factor: 3.673

6.  Ribozyme-mediated cleavage of the MDR-1 transcript restores chemosensitivity in previously resistant cancer cells.

Authors:  M Kiehntopf; M A Brach; T Licht; S Petschauer; L Karawajew; C Kirschning; F Herrmann
Journal:  EMBO J       Date:  1994-10-03       Impact factor: 11.598

7.  Mechanistic basis for multidrug resistance and collateral drug sensitivity conferred to the malaria parasite by polymorphisms in PfMDR1 and PfCRT.

Authors:  Sarah Heckmatt Shafik; Sashika Natasha Richards; Ben Corry; Rowena Elizabeth Martin
Journal:  PLoS Biol       Date:  2022-05-04       Impact factor: 9.593

8.  Progress in the development of early diagnosis and a drug with unique pharmacology to improve cancer therapy.

Authors:  A Lehotzky; N Tokési; I Gonzalez-Alvarez; V Merino; M Bermejo; F Orosz; P Lau; G G Kovacs; J Ovádi
Journal:  Philos Trans A Math Phys Eng Sci       Date:  2008-10-13       Impact factor: 4.226

9.  Selective modulation of vinblastine sensitivity by 1,9-dideoxyforskolin and related diterpenes in multidrug resistant tumour cells.

Authors:  D R Shalinsky; D D Heath; A P Jekunen; J E Alcaraz; S B Howell
Journal:  Br J Cancer       Date:  1993-03       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.